BMO Capital Markets restated their market perform rating on shares of Universal Health Services (NYSE:UHS) in a report released on Thursday, AnalystRatingsNetwork reports. BMO Capital Markets currently has a $75.00 price objective on the stock, up from their previous price objective of $70.00.
“Universal Health’s acute care unit posted better-than-expected results for the third quarter, including same-facility revenue growth of 6.6%. Key services, such as inpatient and outpatient surgeries, moved into positive growth territory in the period helping to drive quarterly outperformance. The Temecula facility is now open for business and start-up costs are expected to be minimal next quarter (~$9M). Behavioral health continued to deliver strong same-facility admissions growth, although length of stay put some downward pressure on top-line expansion. The company anticipates some behavioral capacity expansion in the near term, which could come in the form of de novo projects or adding beds to existing service platforms. We are raising our estimates to reflect the TX Medicaid true up and stronger acute fundamentals, partially offset by continued pressure on behavioral length of stay.,” the firm’s analyst commented.
BMO Capital Markets has also updated their ratings on a number of other healthcare stocks in the last week. The firm raised its price target on shares of Acadia Healthcare Co Inc from $40.00 to $47.00. They have an outperform rating on that stock.
Other equities research analysts have also recently issued reports about the stock. Analysts at UBS AG raised their price target on shares of Universal Health Services from $78.00 to $91.00 in a research note to investors on Wednesday, October 30th. They now have a buy rating on the stock. Separately, analysts at Credit Suisse raised their price target on shares of Universal Health Services from $77.00 to $89.00 in a research note to investors on Wednesday, October 30th. They now have an outperform rating on the stock. Finally, analysts at Deutsche Bank reiterated a buy rating on shares of Universal Health Services in a research note to investors on Tuesday, October 15th. They now have a $88.00 price target on the stock. Four analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The stock has a consensus rating of Buy and a consensus target price of $80.75.
Shares of Universal Health Services (NYSE:UHS) traded up 0.71% during mid-day trading on Thursday, hitting $81.35. The stock had a trading volume of 336,436 shares. Universal Health Services has a 1-year low of $40.76 and a 1-year high of $81.69. The stock has a 50-day moving average of $76.69 and a 200-day moving average of $70.11. The company has a market cap of $7.985 billion and a price-to-earnings ratio of 15.33.
Universal Health Services (NYSE:UHS) last announced its earnings results on Wednesday, October 30th. The company reported $1.15 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.02 by $0.13. The company had revenue of $1.82 million for the quarter, compared to the consensus estimate of $1.79 billion. During the same quarter last year, the company posted $0.91 earnings per share. Universal Health Services’s revenue was up 14.2% compared to the same quarter last year. Analysts expect that Universal Health Services will post $4.55 EPS for the current fiscal year.
Universal Health Services, Inc owns and operates through its subsidiaries, acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.